BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 9385124)

  • 1. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age.
    Szabó J; Gellén J; Szemere G
    Ultrasound Obstet Gynecol; 1995 Mar; 5(3):161-3. PubMed ID: 7788489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome.
    Malone FD; Ball RH; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Canick JA; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):288-94. PubMed ID: 16055577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonography of the fetal neck in the first and second trimesters. Part 2. Anomalies of the posterior nuchal region.
    Suchet IB
    Can Assoc Radiol J; 1995 Oct; 46(5):344-52. PubMed ID: 7552826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality.
    van Vugt JM; van Zalen-Sprock RM; Kostense PJ
    Radiology; 1996 Aug; 200(2):537-40. PubMed ID: 8685353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuchal thickening or cystic hygromas in first- and early second-trimester fetuses: prognosis and outcome.
    Nadel A; Bromley B; Benacerraf BR
    Obstet Gynecol; 1993 Jul; 82(1):43-8. PubMed ID: 8515924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
    Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
    BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness].
    Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A
    Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.